LENZ Therapeutics and Everest Medicines Partner to Advance VIZZ in Greater China
SAN DIEGO, June 7, 2026 LENZ Therapeutics announced that Everest Medicines has acquired the rights to develop, manufacture, and...
FDA Approved
Advertisement
Alkem Launches India’s First Semaglutide Pre-Filled Syringe
MUMBAI, India, June 2, 2026 Alkem Laboratories has announced the launch of India’s first semaglutide single-shot pre-filled syringes, marking...
Otsuka’s VOYXACT Preserves Kidney Function in Phase 3 IgAN Trial
GLASGOW, Scotland, June 4, 2026 Otsuka Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Development & Commercialization, Inc. have announced positive...
Acadia Expands DAYBUE STIX Access for Rett Syndrome
San Diego, California, USA, April 7, 2026 Broad U.S. Availability Expands Patient Access In a major advancement for rare...
Johnson & Johnson INLEXZO Gets J-Code for Cancer Access
RARITAN, N.J., USA — April 1, 2026 Johnson & Johnson announced that its innovative bladder cancer therapy INLEXZO™ (gemcitabine...
Advertisement
